VAERS Explorer
Back to explore

Report #2879604

Received Dec 25, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Female
Age
Age unknown
State
—
Recovered
Not recovered
Vaccinated
Dec 19, 2025
Onset
—
Days to onset
—
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
VARZOSZOSTER (SHINGRIX)GLAXOSMITHKLINE BIOLOGICALSUNK3t74x—

Symptoms (4)

BlisterChillsMyalgiaPyrexia

Symptom narrative

fever; blisters all over my body; chills; muscle pain; This non-serious case was reported by a consumer and described the occurrence of fever in a 54-year-old female patient who received Herpes zoster (Shingrix) (batch number 3t74x, expiry date 19-DEC-2026) for prophylaxis. On 19-DEC-2025, the patient received Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced fever (Verbatim: fever), blister (Verbatim: blisters all over my body), chills (Verbatim: chills) and muscle pain (Verbatim: muscle pain). The outcome of the fever, blister, chills and muscle pain were not resolved. It was unknown if the reporter considered the fever, blister, chills and muscle pain to be related to Shingrix. It was unknown if the company considered the fever, blister, chills and muscle pain to be related to Shingrix.